Skip to main content
Steven Grossman, MD, Oncology, Los Angeles, CA, Keck Hospital of USC

StevenR.GrossmanMD

Oncology Los Angeles, CA

Professor of Medicine, Keck School of Medicine, University of Southern California

Dr. Grossman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Grossman's full profile

Already have an account?

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1994 - 1997
  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 1991 - 1993
  • University of Chicago Division of the Biological Sciences The Pritzker School of Medicine
    University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1991

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2021 - 2025
  • VA State Medical License
    VA State Medical License 2011 - 2024
  • MA State Medical License
    MA State Medical License 1993 - 2012
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Press Mentions

  • Dr. Steven Grossman Appointed 1st Chief Cancer Physician of USC Norris Comprehensive Cancer Center
    Dr. Steven Grossman Appointed 1st Chief Cancer Physician of USC Norris Comprehensive Cancer CenterAugust 12th, 2020
  • New p53 Gene Discovery Sheds Light on How to Make Cancer Therapies More Effective
    New p53 Gene Discovery Sheds Light on How to Make Cancer Therapies More EffectiveJune 21st, 2019
  • Study Uncovers Potential ‘Silver Bullet’ for Preventing and Treating Colon Cancer
    Study Uncovers Potential ‘Silver Bullet’ for Preventing and Treating Colon CancerJuly 27th, 2017

Grant Support

  • Role Of P300/Cbp And Hhr23 Proteins In P53 RegulationNational Cancer Institute2011–2012
  • Role Of P300/Cbp And Hhr23 Proteins In P53 RegulationNational Cancer Institute2010–2011
  • Targeting The Arf/Ctbp Axis In Pancreatic CancerNational Cancer Institute2009–2010
  • Role Of P300 And Hhr23 Proteins In P53 RegulationNational Cancer Institute2005–2008
  • Role Of MDM2, P300, P19ARF In P53 UbiquitinationNational Cancer Institute2003–2005
  • P300 And Hhr23 Proteins In P53 RegulationNational Cancer Institute2004
  • Role Of MDM2, P300, P19ARF In P53 UbiquitinationNational Cancer Institute2001–2002

Hospital Affiliations